Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Selenite antagonizes the anticancer activity of imatinib in human laryngeal cancer cells.

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ABDEL-AZIZ, Amal Kamal (Faculty of Pharmacy, Ain Shams University, Department of Pharmacology and Toxicology, Cairo, Egypt)
  • Co-author(s): Amal Kamal Abdel-Aziz: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Samar Azab : Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Abeer El-Sayed: Tissue culture and cytogenetics unit, Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
    Ebtehal El-Demerdash : Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Samia Shouman: Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
  • Abstract:

    Backgrounds

    Laryngeal cancer is the most common type of head and neck carcinomas. To date, limited anticancer agents are effective in treating laryngeal cancer whose survival rates are non-satisfactory. Although preferential overexpression of several tyrosine receptors has been demonstrated in heads and neck carcinoma specimens compared to benign

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses